MSFinals-2593
A 43-year-old woman is undergoing investigation for symmetrical polyarthritis that is widespread. She reports experiencing a blue tinge in her fingers during cold weather. During examination, a prominent rash is observed over her nose and cheeks, but not in her nasolabial folds. Her blood tests show positive results for anti-dsDNA. She is advised to take a drug that is described as a ‘disease-modifying’ drug. What kind of regular monitoring will she need while undergoing treatment?